SCHEMBL7063104

SCHEMBL7063104

Cn1c2c(c(=O)n(Cc3ccc(F)c(F)c3)c1=O)S(=O)(=O)C(C(=O)O)C(=O)N2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.35
LMNA P02545 1/20 0.35
PTGS1 P23219 2/20 0.34
PTGS2 P35354 2/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33
BRD4 O60885 1/20 0.33
GPR18 Q14330 1/20 0.32
P2RX3 P56373 1/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2B Q13224 2/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7058690 0.89 GAA (0.34) ALDH1A1L3MBTL1MEN1CYP3A4CYP2C9
SCHEMBL7123002 0.85 ALDH1A1 (0.38) ALDH1A1TSHRMEN1CYP3A4CYP2C9
SCHEMBL7061898 0.85 GAA (0.47) ALDH1A1L3MBTL1MEN1CYP3A4CYP2C9
SCHEMBL6678209 0.79 ALDH1A1 (0.38) ALDH1A1L3MBTL1TSHRMEN1CYP3A4
SCHEMBL7062549 0.78 ALDH1A1 (0.40) ALDH1A1L3MBTL1MEN1CYP3A4CYP2C9
SCHEMBL7059284 0.78 PTGS1 (0.34) ALDH1A1L3MBTL1TSHRPTGS1PTGS2
SCHEMBL7061528 0.77 ALDH1A1 (0.36) ALDH1A1L3MBTL1TSHRMEN1CYP3A4
SCHEMBL7127312 0.76 ALDH1A1 (0.49) ALDH1A1L3MBTL1TSHRMEN1CYP3A4
SCHEMBL7125681 0.76 L3MBTL1 (0.41) ALDH1A1L3MBTL1MEN1KMT2AGAA
SCHEMBL7119000 0.72 MEN1 (0.40) ALDH1A1L3MBTL1MEN1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040224951-A1 5,6-Fused uracil derivatives as matrix metalloproteinase inhibitors ROARK WILLIAM HOWARD (US) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224951-A1 5,6-Fused uracil derivatives as matrix metalloproteinase inhibitors MMP9, MMP13, MMP25 ALDH1A1 812/4885L3MBTL1 2277/4885TSHR 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.